Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03189303 · ClinicalTrials.gov registry record
Cup Position in THA With Standard Instruments
A clinical trial, sponsored by DePuy Orthopaedics.
- Completed
- Registry status
- 183
- Enrollment target
NCT03189303: Completed study, sponsored by DePuy Orthopaedics.
NCT03189303 is a clinical trial that has completed, run by DePuy Orthopaedics. The registered enrollment target is 183 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03189303 has completed, sponsored by DePuy Orthopaedics.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
Study Summary
Prospective, global, multicenter study to assess cup position in THA. After written informed consent has been obtained, study evaluations will be collected from the pre-op clinic visit, the operative visit (including discharge), and 6 and 12 weeks postoperatively.
Primary Outcome
The primary endpoint is acetabular cup position success at 6 weeks postoperatively. It is a composite endpoint; in order for an individual cup position to be considered successful, the cup's placement must satisfy all of the following criteria at 6 weeks: 1. Inclination Success: within 10 degrees of the planned inclination 2. Version Success: within 10 degrees of the planned version
Interventions
- DEVICE Primary Uncemented Total Hip Arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2021-12-14 |
What the finished NCT03189303 record still lists
NCT03189303 is an observational study that tracks outcomes without assigning an intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Primary Uncemented Total Hip Arthroplasty is the first listed.
NCT03189303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03189303 about?
NCT03189303 is a clinical study titled "Cup Position in THA With Standard Instruments". Prospective, global, multicenter study to assess cup position in THA. After written informed consent has been obtained, study evaluations will be collected from the pre-op clinic visit, the operative visit (including discharge), and 6 and 12 weeks postoperatively.
What is the current status of trial NCT03189303?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2017-09-07. Estimated completion is 2021-12-14.
What interventions are being tested in trial NCT03189303?
The interventions under investigation include: Primary Uncemented Total Hip Arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT03189303?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI